LG AI Strategy Journal
Source card

LG AI Research Announces Collaboration with D&D Pharmatech to accelerate next-generation oral peptide drug discovery

PRNewswire / LG AI Research 원문 열기 ↗

| 항목 | 내용 |

AI for ScienceAI AllianceAI InfraPhysical AIAI MobilityEnterprise AX

LG AI Research Announces Collaboration with D&D Pharmatech to accelerate next-generation oral peptide drug discovery

1. Source Identity

항목 내용
발행기관 PRNewswire / LG AI Research
저자·발표자 unknown
원문 유형 official_page
발행일·수정일 2026-06-17 / Wed, 17 Jun 2026 14:00:26 GMT
수집일 2026-06-21
원문 언어 en
원문 URL https://www.prnewswire.com/news-releases/lg-ai-research-announces-collaboration-with-dd-pharmatech-to-accelerate-next-generation-oral-peptide-drug-discovery-302802738.html
최종 도달 URL https://www.prnewswire.com/news-releases/lg-ai-research-announces-collaboration-with-dd-pharmatech-to-accelerate-next-generation-oral-peptide-drug-discovery-302802738.html
수집 범위 complete
라이선스 unknown

2. Evidence Abstract

LG AI Research와 D&D Pharmatech는 차세대 경구용 펩타이드 신약 공동개발 계약을 체결했다. LG AI Research는 펩타이드 후보물질 발견·설계 모델을 개발한다. D&D Pharmatech는 구조 설계, 합성, 평가, 제형, 전임상·임상, 글로벌 규제 승인 절차를 담당한다. 두 회사는 AI 후보 제안과 실험 검증 결과 피드백을 연결하는 continuous feedback loop를 구축할 계획이다. Cancer Agentic AI와 EXAONE Discovery 등 Biology AI 포트폴리오가 함께 언급된다. LG AI Research와 D&D Pharmatech는 next-generation oral peptide drug discovery 협력을 발표했다. LG AI Research는 AI 기반 peptide candidate discovery and design models를 담당한다.

3. Atomic Claims

claim_id 원문 위치 주체 주장·사실 수치·기간 근거 유형 확실성
src_lgai_dd_pharmatech_20260617_c01 Source Notes / 원문 재확인 필요 LG AI Research LG AI Research와 D&D Pharmatech는 차세대 경구용 펩타이드 신약 공동개발 계약을 체결했다. - statement high
src_lgai_dd_pharmatech_20260617_c02 Source Notes / 원문 재확인 필요 LG AI Research LG AI Research는 펩타이드 후보물질 발견·설계 모델을 개발한다. - statement high
src_lgai_dd_pharmatech_20260617_c03 Source Notes / 원문 재확인 필요 D&D Pharmatech D&D Pharmatech는 구조 설계, 합성, 평가, 제형, 전임상·임상, 글로벌 규제 승인 절차를 담당한다. - statement high
src_lgai_dd_pharmatech_20260617_c04 Source Notes / 원문 재확인 필요 PRNewswire / LG AI Research 두 회사는 AI 후보 제안과 실험 검증 결과 피드백을 연결하는 continuous feedback loop를 구축할 계획이다. - statement medium
src_lgai_dd_pharmatech_20260617_c05 Source Notes / 원문 재확인 필요 PRNewswire / LG AI Research Cancer Agentic AI와 EXAONE Discovery 등 Biology AI 포트폴리오가 함께 언급된다. - statement high
src_lgai_dd_pharmatech_20260617_c06 Source Notes / 원문 재확인 필요 LG AI Research LG AI Research와 D&D Pharmatech는 next-generation oral peptide drug discovery 협력을 발표했다. - statement high
src_lgai_dd_pharmatech_20260617_c07 Source Notes / 원문 재확인 필요 LG AI Research LG AI Research는 AI 기반 peptide candidate discovery and design models를 담당한다. - statement high
src_lgai_dd_pharmatech_20260617_c08 Source Notes / 원문 재확인 필요 D&D Pharmatech [원문 언어 기록] D&D Pharmatech는 peptide structure design, synthesis, evaluation, formulation, preclinical and clinical development를 담당한다. - statement high
src_lgai_dd_pharmatech_20260617_c09 Source Notes / 원문 재확인 필요 PRNewswire / LG AI Research 두 회사는 AI candidate proposal과 experimental validation feedback을 연결하는 continuous feedback loop를 구축할 계획이다. - statement medium
src_lgai_dd_pharmatech_20260617_c10 Source Notes / 원문 재확인 필요 D&D Pharmatech [원문 언어 기록] EXAONE Discovery와 D&D Pharmatech의 AI-driven oral peptide drug discovery collaboration. - statement high
src_lgai_dd_pharmatech_20260617_c11 Source Notes / 원문 재확인 필요 LG AI Research [원문 언어 기록] LG AI Research–D&D Pharmatech next-generation oral peptide drug discovery collaboration, candidate design, wet-lab validation, clinical/regulatory linkage. - statement high

4. Entities and Relationships

주체 관계 대상 원문 근거 유효시점
LG AI Research develops D&D Pharmatech src_lgai_dd_pharmatech_20260617_c01 2026-06-17
LG AI Research partnered_with D&D Pharmatech src_lgai_dd_pharmatech_20260617_c06 2026-06-17
LG AI Research partnered_with D&D Pharmatech src_lgai_dd_pharmatech_20260617_c11 2026-06-17

5. Numbers, Dates, and Commitments

항목 값 단위 기준시점 성격 claim_id
명시적 수치 없음 - - - not_applicable -

6. Definitions and Terminology

원문 용어 한국어 표기 원문에서의 의미 Wiki Concept 후보
ai co scientist AI Co-Scientist 이 Source가 관련 근거로 사용되는 개념 AI Co-Scientist
ai for science AI for Science 이 Source가 관련 근거로 사용되는 개념 AI for Science
battery materials Battery Materials 이 Source가 관련 근거로 사용되는 개념 Battery Materials
bio intelligence Bio Intelligence 이 Source가 관련 근거로 사용되는 개념 Bio Intelligence
chemical agentic ai Chemical Agentic AI 이 Source가 관련 근거로 사용되는 개념 Chemical Agentic AI
closed loop rnd Closed-loop R&D 이 Source가 관련 근거로 사용되는 개념 Closed-loop R&D
cvc Corporate Venture Capital 이 Source가 관련 근거로 사용되는 개념 Corporate Venture Capital
exaone discovery EXAONE Discovery 이 Source가 관련 근거로 사용되는 개념 EXAONE Discovery
hybrid ai strategy Hybrid AI Strategy 이 Source가 관련 근거로 사용되는 개념 Hybrid AI Strategy
industrial ai ecosystem Industrial AI Ecosystem 이 Source가 관련 근거로 사용되는 개념 Industrial AI Ecosystem
materials informatics Materials Informatics 이 Source가 관련 근거로 사용되는 개념 Materials Informatics
materials intelligence Materials Intelligence 이 Source가 관련 근거로 사용되는 개념 Materials Intelligence
open innovation Open Innovation 이 Source가 관련 근거로 사용되는 개념 Open Innovation
partner technology transfer Partner Technology Transfer 이 Source가 관련 근거로 사용되는 개념 Partner Technology Transfer
patent intelligence Patent Intelligence 이 Source가 관련 근거로 사용되는 개념 Patent Intelligence
peptide drug discovery Peptide Drug Discovery 이 Source가 관련 근거로 사용되는 개념 Peptide Drug Discovery
strategic alliance governance Strategic Alliance Governance 이 Source가 관련 근거로 사용되는 개념 Strategic Alliance Governance

7. Figures, Tables, and Images

asset_id 유형 원문 위치 설명·읽을 수 있는 사실 original_url local_path status
lgai_dd_pharmatech_image_needed image 원문 또는 Source Notes LG AI Research와 D&D Pharmatech의 차세대 oral peptide drug discovery 협력. 원문 페이지의 직접 이미지 URL은 별도 확보 필요. IMAGE_URL_NEEDED image_url_needed

8. Source Limitations

  • Source Card의 한국어 기록은 원문을 대체하지 않으며, 전략적 해석은 Docs와 Topics에서 관리한다.
  • 기존 Source Notes에서 승격한 claim은 원문 section·page 위치를 재확인해야 한다.

9. Reliability Assessment

평가 항목 판단 이유
출처 직접성 high PRNewswire / LG AI Research의 자료 유형과 발행 주체를 기준으로 평가
사실 검증성 high 기존 Source Notes에 11개 핵심 사실이 구조화되어 있음
최신성 current 발행일 2026-06-17 기준
이해관계 high 공식 발표자료는 직접성이 높지만 발행 주체의 이해관계를 포함함
종합 등급 B 원문 직접성, 접근성, 기존 facts의 구체성을 종합 평가

10. Used In

Entity 사용한 claim_id 사용 방식
AI for Science: Bio·Materials·Battery src_lgai_dd_pharmatech_20260617_c01, src_lgai_dd_pharmatech_20260617_c02, src_lgai_dd_pharmatech_20260617_c03, src_lgai_dd_pharmatech_20260617_c04, src_lgai_dd_pharmatech_20260617_c05, src_lgai_dd_pharmatech_20260617_c06, src_lgai_dd_pharmatech_20260617_c07, src_lgai_dd_pharmatech_20260617_c08, src_lgai_dd_pharmatech_20260617_c09, src_lgai_dd_pharmatech_20260617_c10, src_lgai_dd_pharmatech_20260617_c11 전략·시장 근거
Global AI Alliance / Open Innovation Network src_lgai_dd_pharmatech_20260617_c01, src_lgai_dd_pharmatech_20260617_c02, src_lgai_dd_pharmatech_20260617_c03, src_lgai_dd_pharmatech_20260617_c04, src_lgai_dd_pharmatech_20260617_c05, src_lgai_dd_pharmatech_20260617_c06, src_lgai_dd_pharmatech_20260617_c07, src_lgai_dd_pharmatech_20260617_c08, src_lgai_dd_pharmatech_20260617_c09, src_lgai_dd_pharmatech_20260617_c10, src_lgai_dd_pharmatech_20260617_c11 전략·시장 근거
AI Alliance는 옵션이지만, 내부화하지 않으면 종속이 된다 src_lgai_dd_pharmatech_20260617_c01, src_lgai_dd_pharmatech_20260617_c02, src_lgai_dd_pharmatech_20260617_c03, src_lgai_dd_pharmatech_20260617_c04, src_lgai_dd_pharmatech_20260617_c05, src_lgai_dd_pharmatech_20260617_c06, src_lgai_dd_pharmatech_20260617_c07, src_lgai_dd_pharmatech_20260617_c08, src_lgai_dd_pharmatech_20260617_c09, src_lgai_dd_pharmatech_20260617_c10, src_lgai_dd_pharmatech_20260617_c11 사업기회·전략 근거
AI for Science는 R&D의 속도를 바꾸지만, 성공률을 자동으로 보장하지는 않는다 src_lgai_dd_pharmatech_20260617_c01, src_lgai_dd_pharmatech_20260617_c02, src_lgai_dd_pharmatech_20260617_c03, src_lgai_dd_pharmatech_20260617_c04, src_lgai_dd_pharmatech_20260617_c05, src_lgai_dd_pharmatech_20260617_c06, src_lgai_dd_pharmatech_20260617_c07, src_lgai_dd_pharmatech_20260617_c08, src_lgai_dd_pharmatech_20260617_c09, src_lgai_dd_pharmatech_20260617_c10, src_lgai_dd_pharmatech_20260617_c11 사업기회·전략 근거
AI Co-Scientist src_lgai_dd_pharmatech_20260617_c01, src_lgai_dd_pharmatech_20260617_c02, src_lgai_dd_pharmatech_20260617_c03, src_lgai_dd_pharmatech_20260617_c04, src_lgai_dd_pharmatech_20260617_c05, src_lgai_dd_pharmatech_20260617_c06, src_lgai_dd_pharmatech_20260617_c07, src_lgai_dd_pharmatech_20260617_c08, src_lgai_dd_pharmatech_20260617_c09, src_lgai_dd_pharmatech_20260617_c10, src_lgai_dd_pharmatech_20260617_c11 개념 정의·맥락 근거
AI for Science src_lgai_dd_pharmatech_20260617_c01, src_lgai_dd_pharmatech_20260617_c02, src_lgai_dd_pharmatech_20260617_c03, src_lgai_dd_pharmatech_20260617_c04, src_lgai_dd_pharmatech_20260617_c05, src_lgai_dd_pharmatech_20260617_c06, src_lgai_dd_pharmatech_20260617_c07, src_lgai_dd_pharmatech_20260617_c08, src_lgai_dd_pharmatech_20260617_c09, src_lgai_dd_pharmatech_20260617_c10, src_lgai_dd_pharmatech_20260617_c11 개념 정의·맥락 근거
Battery Materials src_lgai_dd_pharmatech_20260617_c01, src_lgai_dd_pharmatech_20260617_c02, src_lgai_dd_pharmatech_20260617_c03, src_lgai_dd_pharmatech_20260617_c04, src_lgai_dd_pharmatech_20260617_c05, src_lgai_dd_pharmatech_20260617_c06, src_lgai_dd_pharmatech_20260617_c07, src_lgai_dd_pharmatech_20260617_c08, src_lgai_dd_pharmatech_20260617_c09, src_lgai_dd_pharmatech_20260617_c10, src_lgai_dd_pharmatech_20260617_c11 개념 정의·맥락 근거
Bio Intelligence src_lgai_dd_pharmatech_20260617_c01, src_lgai_dd_pharmatech_20260617_c02, src_lgai_dd_pharmatech_20260617_c03, src_lgai_dd_pharmatech_20260617_c04, src_lgai_dd_pharmatech_20260617_c05, src_lgai_dd_pharmatech_20260617_c06, src_lgai_dd_pharmatech_20260617_c07, src_lgai_dd_pharmatech_20260617_c08, src_lgai_dd_pharmatech_20260617_c09, src_lgai_dd_pharmatech_20260617_c10, src_lgai_dd_pharmatech_20260617_c11 개념 정의·맥락 근거
Chemical Agentic AI src_lgai_dd_pharmatech_20260617_c01, src_lgai_dd_pharmatech_20260617_c02, src_lgai_dd_pharmatech_20260617_c03, src_lgai_dd_pharmatech_20260617_c04, src_lgai_dd_pharmatech_20260617_c05, src_lgai_dd_pharmatech_20260617_c06, src_lgai_dd_pharmatech_20260617_c07, src_lgai_dd_pharmatech_20260617_c08, src_lgai_dd_pharmatech_20260617_c09, src_lgai_dd_pharmatech_20260617_c10, src_lgai_dd_pharmatech_20260617_c11 개념 정의·맥락 근거
Closed-loop R&D src_lgai_dd_pharmatech_20260617_c01, src_lgai_dd_pharmatech_20260617_c02, src_lgai_dd_pharmatech_20260617_c03, src_lgai_dd_pharmatech_20260617_c04, src_lgai_dd_pharmatech_20260617_c05, src_lgai_dd_pharmatech_20260617_c06, src_lgai_dd_pharmatech_20260617_c07, src_lgai_dd_pharmatech_20260617_c08, src_lgai_dd_pharmatech_20260617_c09, src_lgai_dd_pharmatech_20260617_c10, src_lgai_dd_pharmatech_20260617_c11 개념 정의·맥락 근거
Corporate Venture Capital src_lgai_dd_pharmatech_20260617_c01, src_lgai_dd_pharmatech_20260617_c02, src_lgai_dd_pharmatech_20260617_c03, src_lgai_dd_pharmatech_20260617_c04, src_lgai_dd_pharmatech_20260617_c05, src_lgai_dd_pharmatech_20260617_c06, src_lgai_dd_pharmatech_20260617_c07, src_lgai_dd_pharmatech_20260617_c08, src_lgai_dd_pharmatech_20260617_c09, src_lgai_dd_pharmatech_20260617_c10, src_lgai_dd_pharmatech_20260617_c11 개념 정의·맥락 근거
EXAONE Discovery src_lgai_dd_pharmatech_20260617_c01, src_lgai_dd_pharmatech_20260617_c02, src_lgai_dd_pharmatech_20260617_c03, src_lgai_dd_pharmatech_20260617_c04, src_lgai_dd_pharmatech_20260617_c05, src_lgai_dd_pharmatech_20260617_c06, src_lgai_dd_pharmatech_20260617_c07, src_lgai_dd_pharmatech_20260617_c08, src_lgai_dd_pharmatech_20260617_c09, src_lgai_dd_pharmatech_20260617_c10, src_lgai_dd_pharmatech_20260617_c11 개념 정의·맥락 근거
Hybrid AI Strategy src_lgai_dd_pharmatech_20260617_c01, src_lgai_dd_pharmatech_20260617_c02, src_lgai_dd_pharmatech_20260617_c03, src_lgai_dd_pharmatech_20260617_c04, src_lgai_dd_pharmatech_20260617_c05, src_lgai_dd_pharmatech_20260617_c06, src_lgai_dd_pharmatech_20260617_c07, src_lgai_dd_pharmatech_20260617_c08, src_lgai_dd_pharmatech_20260617_c09, src_lgai_dd_pharmatech_20260617_c10, src_lgai_dd_pharmatech_20260617_c11 개념 정의·맥락 근거
Industrial AI Ecosystem src_lgai_dd_pharmatech_20260617_c01, src_lgai_dd_pharmatech_20260617_c02, src_lgai_dd_pharmatech_20260617_c03, src_lgai_dd_pharmatech_20260617_c04, src_lgai_dd_pharmatech_20260617_c05, src_lgai_dd_pharmatech_20260617_c06, src_lgai_dd_pharmatech_20260617_c07, src_lgai_dd_pharmatech_20260617_c08, src_lgai_dd_pharmatech_20260617_c09, src_lgai_dd_pharmatech_20260617_c10, src_lgai_dd_pharmatech_20260617_c11 개념 정의·맥락 근거
Materials Informatics src_lgai_dd_pharmatech_20260617_c01, src_lgai_dd_pharmatech_20260617_c02, src_lgai_dd_pharmatech_20260617_c03, src_lgai_dd_pharmatech_20260617_c04, src_lgai_dd_pharmatech_20260617_c05, src_lgai_dd_pharmatech_20260617_c06, src_lgai_dd_pharmatech_20260617_c07, src_lgai_dd_pharmatech_20260617_c08, src_lgai_dd_pharmatech_20260617_c09, src_lgai_dd_pharmatech_20260617_c10, src_lgai_dd_pharmatech_20260617_c11 개념 정의·맥락 근거
Materials Intelligence src_lgai_dd_pharmatech_20260617_c01, src_lgai_dd_pharmatech_20260617_c02, src_lgai_dd_pharmatech_20260617_c03, src_lgai_dd_pharmatech_20260617_c04, src_lgai_dd_pharmatech_20260617_c05, src_lgai_dd_pharmatech_20260617_c06, src_lgai_dd_pharmatech_20260617_c07, src_lgai_dd_pharmatech_20260617_c08, src_lgai_dd_pharmatech_20260617_c09, src_lgai_dd_pharmatech_20260617_c10, src_lgai_dd_pharmatech_20260617_c11 개념 정의·맥락 근거
Open Innovation src_lgai_dd_pharmatech_20260617_c01, src_lgai_dd_pharmatech_20260617_c02, src_lgai_dd_pharmatech_20260617_c03, src_lgai_dd_pharmatech_20260617_c04, src_lgai_dd_pharmatech_20260617_c05, src_lgai_dd_pharmatech_20260617_c06, src_lgai_dd_pharmatech_20260617_c07, src_lgai_dd_pharmatech_20260617_c08, src_lgai_dd_pharmatech_20260617_c09, src_lgai_dd_pharmatech_20260617_c10, src_lgai_dd_pharmatech_20260617_c11 개념 정의·맥락 근거
Partner Technology Transfer src_lgai_dd_pharmatech_20260617_c01, src_lgai_dd_pharmatech_20260617_c02, src_lgai_dd_pharmatech_20260617_c03, src_lgai_dd_pharmatech_20260617_c04, src_lgai_dd_pharmatech_20260617_c05, src_lgai_dd_pharmatech_20260617_c06, src_lgai_dd_pharmatech_20260617_c07, src_lgai_dd_pharmatech_20260617_c08, src_lgai_dd_pharmatech_20260617_c09, src_lgai_dd_pharmatech_20260617_c10, src_lgai_dd_pharmatech_20260617_c11 개념 정의·맥락 근거
Patent Intelligence src_lgai_dd_pharmatech_20260617_c01, src_lgai_dd_pharmatech_20260617_c02, src_lgai_dd_pharmatech_20260617_c03, src_lgai_dd_pharmatech_20260617_c04, src_lgai_dd_pharmatech_20260617_c05, src_lgai_dd_pharmatech_20260617_c06, src_lgai_dd_pharmatech_20260617_c07, src_lgai_dd_pharmatech_20260617_c08, src_lgai_dd_pharmatech_20260617_c09, src_lgai_dd_pharmatech_20260617_c10, src_lgai_dd_pharmatech_20260617_c11 개념 정의·맥락 근거
Peptide Drug Discovery src_lgai_dd_pharmatech_20260617_c01, src_lgai_dd_pharmatech_20260617_c02, src_lgai_dd_pharmatech_20260617_c03, src_lgai_dd_pharmatech_20260617_c04, src_lgai_dd_pharmatech_20260617_c05, src_lgai_dd_pharmatech_20260617_c06, src_lgai_dd_pharmatech_20260617_c07, src_lgai_dd_pharmatech_20260617_c08, src_lgai_dd_pharmatech_20260617_c09, src_lgai_dd_pharmatech_20260617_c10, src_lgai_dd_pharmatech_20260617_c11 개념 정의·맥락 근거
Strategic Alliance Governance src_lgai_dd_pharmatech_20260617_c01, src_lgai_dd_pharmatech_20260617_c02, src_lgai_dd_pharmatech_20260617_c03, src_lgai_dd_pharmatech_20260617_c04, src_lgai_dd_pharmatech_20260617_c05, src_lgai_dd_pharmatech_20260617_c06, src_lgai_dd_pharmatech_20260617_c07, src_lgai_dd_pharmatech_20260617_c08, src_lgai_dd_pharmatech_20260617_c09, src_lgai_dd_pharmatech_20260617_c10, src_lgai_dd_pharmatech_20260617_c11 개념 정의·맥락 근거
LG AI Research src_lgai_dd_pharmatech_20260617_c01, src_lgai_dd_pharmatech_20260617_c02, src_lgai_dd_pharmatech_20260617_c03, src_lgai_dd_pharmatech_20260617_c04, src_lgai_dd_pharmatech_20260617_c05, src_lgai_dd_pharmatech_20260617_c06, src_lgai_dd_pharmatech_20260617_c07, src_lgai_dd_pharmatech_20260617_c08, src_lgai_dd_pharmatech_20260617_c09, src_lgai_dd_pharmatech_20260617_c10, src_lgai_dd_pharmatech_20260617_c11 기업 역할·연결 근거
LG Technology Ventures src_lgai_dd_pharmatech_20260617_c01, src_lgai_dd_pharmatech_20260617_c02, src_lgai_dd_pharmatech_20260617_c03, src_lgai_dd_pharmatech_20260617_c04, src_lgai_dd_pharmatech_20260617_c05, src_lgai_dd_pharmatech_20260617_c06, src_lgai_dd_pharmatech_20260617_c07, src_lgai_dd_pharmatech_20260617_c08, src_lgai_dd_pharmatech_20260617_c09, src_lgai_dd_pharmatech_20260617_c10, src_lgai_dd_pharmatech_20260617_c11 기업 역할·연결 근거

11. Update Hooks

Appendix A. Permitted Evidence Excerpts

저작권과 검증 목적에 필요한 짧은 원문 발췌는 원문 위치 확인 후 추가한다. 현재 자동 마이그레이션에서는 전체 원문을 복제하지 않았다.

Appendix B. Ingestion Notes

  • 변환 방식: 기존 Source Summary와 Key Facts를 atomic claim으로 승격
  • 원문 수집 상태: fetched
  • HTTP / 오류: 200 / -
  • Content-Type: text/html; charset=UTF-8
  • Content Hash: 2b32a71965f38fbbe3314fe51d715e5c5f79673462d599f7da666dd3d4630cff
  • 감지된 heading 수: 6
  • 제외 범위: navigation, footer, 광고, cookie 문구 및 전체 원문 복제
  • 후속 작업: claim별 원문 section·page 위치를 우선순위에 따라 수동 또는 정밀 파서로 보강
Used in

이 근거를 사용한 전략 질문

Q09 AI Alliance는 옵션이지만, 내부화하지 않으면 종속이 된다↗ Q10 AI for Science는 R&D의 속도를 바꾸지만, 성공률을 자동으로 보장하지는 않는다↗